PMID- 37018737 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20230503 LR - 20230504 IS - 1879-1123 (Electronic) IS - 1044-0305 (Linking) VI - 34 IP - 5 DP - 2023 May 3 TI - Investigation of Unusual N-(Triphenyl-lambda(5)-phosphanylidene) Amide Fragmentation Observed upon MS/MS Collision-Induced Dissociation. PG - 969-976 LID - 10.1021/jasms.3c00051 [doi] AB - A mechanism of unusual tandem (MS/MS) fragmentation of protonated species of N-(triphenyl-lambda(5)-phosphanylidene) derivatives, [M + H](+) to generate triphenylphosphine oxide (TPPO) within the mass spectrometer has been investigated and reported. Collision-induced dissociation of these molecules resulted in the generation of TPPO as a signature fragment. This fragment suggested the presence of a P-O bond in the structure which was contrary to the structure of the compound identified by nuclear magnetic resonance spectrometry (NMR) and single-crystal X-ray diffractometry (SXRD) techniques with a P horizontal lineN bond rather than a P-O bond. In order to confirm the generation of the TPPO fragment within the mass spectrometer, 14 different N-(triphenyl-lambda(5)-phosphanylidene) derivatives containing amide, (18)O-labeled amide, thiamide, and nonacyl phosphazene derivatives were synthesized and their MS/MS behavior was studied by liquid chromatography-high-resolution mass spectrometry. Fragmentation of these amide derivatives generated TPPO/TPPS or their (18)O-labeled analogues as the major fragment in almost all cases under similar MS conditions. Based on the outcome of these experiments, a plausible mechanism for such fragmentation, involving the intramolecular shifting of oxygen from carbon to phosphorus, has been proposed. DFT calculations for the protonated species at B3LYP-D3/6-31+G(d,p) further supported the proposed mechanism involving a four-membered ring, P-O-C-N, as the transition state. Details of this work are presented here. FAU - Kurmi, Moolchand AU - Kurmi M AD - Biocon Bristol Myers Squibb Research & Development Centre (BBRC), Syngene International Limited, Bangalore 560099, India. FAU - Kadambar, Vasantha Krishna AU - Kadambar VK AD - Biocon Bristol Myers Squibb Research & Development Centre (BBRC), Syngene International Limited, Bangalore 560099, India. FAU - Srinivas, Pavan AU - Srinivas P AD - Biocon Bristol Myers Squibb Research & Development Centre (BBRC), Syngene International Limited, Bangalore 560099, India. FAU - Reddi, Yernaidu AU - Reddi Y AUID- ORCID: 0000-0002-6743-9582 AD - Biocon Bristol Myers Squibb Research & Development Centre (BBRC), Syngene International Limited, Bangalore 560099, India. FAU - Panda, Manoranjan AU - Panda M AD - Biocon Bristol Myers Squibb Research & Development Centre (BBRC), Bristol-Myers Squibb, Bangalore 560099, India. FAU - Peddicord, Michael AU - Peddicord M AUID- ORCID: 0000-0003-1930-0647 AD - Bristol Myers Squibb Company, 1 Squibb Drive, New Brunswick, New Jersey 08903, United States. FAU - Miller, Scott A AU - Miller SA AD - Bristol Myers Squibb Company, 1 Squibb Drive, New Brunswick, New Jersey 08903, United States. FAU - Young, Joel AU - Young J AD - Bristol Myers Squibb Company, 1 Squibb Drive, New Brunswick, New Jersey 08903, United States. FAU - Bhutani, Hemant AU - Bhutani H AUID- ORCID: 0000-0001-5443-7257 AD - Biocon Bristol Myers Squibb Research & Development Centre (BBRC), Bristol-Myers Squibb, Bangalore 560099, India. FAU - Bajpai, Lakshmikant AU - Bajpai L AUID- ORCID: 0000-0002-0513-7888 AD - Biocon Bristol Myers Squibb Research & Development Centre (BBRC), Bristol-Myers Squibb, Bangalore 560099, India. LA - eng PT - Journal Article DEP - 20230405 PL - United States TA - J Am Soc Mass Spectrom JT - Journal of the American Society for Mass Spectrometry JID - 9010412 SB - IM EDAT- 2023/04/06 06:00 MHDA- 2023/04/06 06:01 CRDT- 2023/04/05 16:22 PHST- 2023/04/06 06:01 [medline] PHST- 2023/04/06 06:00 [pubmed] PHST- 2023/04/05 16:22 [entrez] AID - 10.1021/jasms.3c00051 [doi] PST - ppublish SO - J Am Soc Mass Spectrom. 2023 May 3;34(5):969-976. doi: 10.1021/jasms.3c00051. Epub 2023 Apr 5.